Grace Therapeutics, Inc. (GRCE) vs PDS Biotechnology Corporation (PDSB)

Grace Therapeutics, Inc. and PDS Biotechnology Corporation are both Biotechnology companies. Grace Therapeutics, Inc. and PDS Biotechnology Corporation are of similar size ($45.4M and $44.2M). Across the 9 metrics below, Grace Therapeutics, Inc. leads on 6 and PDS Biotechnology Corporation on 3.

Valuation

Metric GRCE PDSB Biotechnology median
P/E n/m n/m 7.88
P/S 183.34 n/m 11.47
P/B 0.76 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 116.74 n/m 10.73
Earnings yield (55.66%) (80.00%) (28.84%)
Free cash flow yield (27.88%) (37.14%) (23.03%)

Profitability

Metric GRCE PDSB Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (36.19%) (543.97%) (57.72%)
Return on assets (33.74%) (136.65%) (49.22%)
Return on invested capital (43.36%) 0.00% 0.00%

Growth

Metric GRCE PDSB Biotechnology median
Revenue growth (TTM) 1,286.81% — 5.64%
EPS growth (last fiscal year) 40.51% 28.16% —
Revenue growth, 5-year CAGR (22.91%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GRCE PDSB Biotechnology median
Debt to equity 0.00 (1.21) 0.00
Current ratio 11.47 0.57 4.73
Net debt to EBITDA 1.53 0.50 0.96

Dividend

Metric GRCE PDSB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric GRCE PDSB Biotechnology median
Market cap 45.44m 44.21m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack